Surgery Partners, Inc. (SGRY)
NASDAQ: SGRY · Real-Time Price · USD
25.31
-0.36 (-1.40%)
At close: Feb 21, 2025, 4:00 PM
25.25
-0.06 (-0.24%)
After-hours: Feb 21, 2025, 5:42 PM EST
Surgery Partners Analyst Ratings
Total Analysts
9
Consensus Rating
Buy
Price Target
$37.38
Upside
+47.69%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Hold Maintains $38 → $28 | Hold | Maintains | $38 → $28 | +10.63% | Dec 3, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $49 → $35 | Buy | Maintains | $49 → $35 | +38.29% | Nov 20, 2024 |
| Macquarie | Macquarie | Buy Maintains $34 | Buy | Maintains | $34 | +34.33% | Nov 19, 2024 |
| Macquarie | Macquarie | Buy Maintains $35 → $34 | Buy | Maintains | $35 → $34 | +34.33% | Nov 13, 2024 |
| Macquarie | Macquarie | Buy Maintains $35 | Buy | Maintains | $35 | +38.29% | Nov 4, 2024 |
| UBS | UBS | Strong Buy Initiates $38 | Strong Buy | Initiates | $38 | +50.14% | Oct 14, 2024 |
| Keybanc | Keybanc | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Oct 11, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $43 | Buy | Reiterates | $43 | +69.89% | Oct 4, 2024 |
| Benchmark | Benchmark | Strong Buy Reiterates $50 | Strong Buy | Reiterates | $50 | +97.55% | Aug 26, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $43 | Buy | Reiterates | $43 | +69.89% | Aug 20, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $43 | Buy | Reiterates | $43 | +69.89% | Aug 19, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $38 → $36 | Strong Buy | Maintains | $38 → $36 | +42.24% | Aug 7, 2024 |
| Benchmark | Benchmark | Strong Buy Reiterates $50 | Strong Buy | Reiterates | $50 | +97.55% | Aug 7, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $49 | Buy | Reiterates | $49 | +93.60% | Aug 7, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $43 | Buy | Reiterates | $43 | +69.89% | Jul 10, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $43 | Buy | Reiterates | $43 | +69.89% | Jul 9, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.